Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

5 Dec 2019 07:00

RNS Number : 7186V
MJ Gleeson PLC
05 December 2019
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, will today hold its Annual General Meeting in Sheffield. Dermot Gleeson, Chairman, will make the following comments:

"Demand at Gleeson Homes is strong with net reservations since the start of the current financial year to 30 June 2020 ("FY2020") up more than 10% compared with the same period last year.

"Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 13,042 plots with a gross development value of £1.7 billion, of which 6,910 plots are owned and 6,132 are conditionally purchased.

"The division currently has 64 active sites, compared with 62 at this time last year, but expects to open significantly more sites in the second half of FY2020.

"Strong demand, good mortgage availability and our ability to offer attractive levels of affordability to our customers, means the outlook for the division remains very positive.

 

"The Board expects Gleeson Homes to record an increase in completions for the half year to 31 December 2019 of approximately 10% compared with the prior half year total of 691 units; and an increase in completions for FY2020 of at least 10% compared with the prior year total of 1,529 units.

"Gleeson Strategic Land continues to experience strong demand for consented land. The majority of the division's land sales are expected in the second half of FY2020. Accordingly, and in line with our expectations, results for the first half are expected to be lower than the unusually high results for the first half last year.

"The division's land pipeline currently consists of 64 sites which have the potential to deliver approximately 22,175 plots. The portfolio includes 10 sites which now have planning permission.

"Against this background the Board remains confident that the Group's results for FY2020 will be in line with expectations.

"We announced in September the appointment of Andrew Coppel and Fiona Goldsmith to the Board as non-executive Directors with effect from 1st October 2019. Colin Dearlove, Senior Independent Director and Ross Ancell, Non-Executive Director will be stepping down from the Board in June 2020. The Board would like to thank both Colin and Ross for the invaluable guidance and support they have provided over the years."

 

5 December 2019

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612900

James Thomson

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKMMGZVDGGLZM
Date   Source Headline
9th Apr 20134:11 pmRNSDirector/PDMR Shareholding
2nd Apr 20137:00 amRNSTotal Voting Rights
6th Mar 20133:15 pmRNSDirector/PDMR Shareholding
28th Feb 20137:00 amRNSHalf Yearly Report
28th Feb 20137:00 amRNSTotal Voting Rights
6th Feb 20134:55 pmRNSDirector/PDMR Shareholding
31st Jan 20137:00 amRNSTotal Voting Rights
11th Jan 20137:00 amRNSTrading Statement
8th Jan 201311:03 amRNSDirector/PDMR Shareholding
31st Dec 20127:00 amRNSTotal Voting Rights
7th Dec 201212:02 pmRNSResult of AGM
7th Dec 201211:00 amRNSAGM Statement
6th Dec 20124:25 pmRNSDirector/PDMR Shareholding
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSInterim Management Statement
9th Nov 20129:15 amRNSHolding(s) in Company
7th Nov 20124:26 pmRNSPerformance Share Plan award to Director
5th Nov 20124:04 pmRNSDirector/PDMR Shareholding
31st Oct 20127:00 amRNSTotal Voting Rights
15th Oct 20122:15 pmRNSAdditional Listing
15th Oct 20121:57 pmRNSDirector/PDMR Shareholding
8th Oct 20122:40 pmRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSTotal Voting Rights
21st Sep 20127:00 amRNSFinal Results
7th Sep 20129:37 amRNSDirector/PDMR Shareholding
31st Aug 20127:00 amRNSTotal Voting Rights
7th Aug 20124:06 pmRNSDirector/PDMR Shareholding
31st Jul 20127:00 amRNSTotal Voting Rights
9th Jul 20127:00 amRNSDirector/PDMR Shareholding
4th Jul 20127:00 amRNSTrading Statement
2nd Jul 20127:00 amRNSDirectorate Change
29th Jun 20127:00 amRNSTotal Voting Rights
8th Jun 20123:10 pmRNSDirector/PDMR Shareholding
31st May 20127:00 amRNSTotal Voting Rights
11th May 20124:40 pmRNSSecond Price Monitoring Extn
11th May 20124:35 pmRNSPrice Monitoring Extension
11th May 20127:00 amRNSInterim Management Statement
10th May 201211:56 amRNSDirector/PDMR Shareholding
30th Apr 20127:00 amRNSTotal Voting Rights
13th Apr 20124:35 pmRNSPrice Monitoring Extension
11th Apr 201210:40 amRNSDirector/PDMR Shareholding
30th Mar 20127:00 amRNSTotal Voting Rights
7th Mar 20129:17 amRNSDirector/PDMR Shareholding
29th Feb 20121:42 pmRNSHolding(s) in Company
29th Feb 20127:00 amRNSTotal Voting Rights
27th Feb 201212:29 pmRNSHolding(s) in Company
22nd Feb 20127:00 amRNSHalf Yearly Report
15th Feb 20124:40 pmRNSSecond Price Monitoring Extn
15th Feb 20124:35 pmRNSPrice Monitoring Extension
7th Feb 20124:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.